Acetyl-Adhesin (1025-1044) amide
- 品牌:cellmano
- 型号:A-4001
- 产地:合肥
- 供应商:合肥赛曼诺生物科技有限公司
- 供应商报价:¥0
- 标签:Acetyl-Adhesin (1025-1044) amide、Acetyl-Adhesin (1025-1044) amide价格、Acetyl-Adhesin (1025-1044) amide厂家、Acetyl-Adhesin (1025-1044) amide、、合肥赛曼诺生物科技有限公司
| A-4001 | Acetyl-Adhesin (1025-1044) amide | C97H160N26O32 | 2202.49 | 320350-56-9 | Ac-Gln-Leu-Lys-Thr-Ala-Asp-Leu-Pro-Ala-Gly-Arg-Asp-Glu-Thr-Thr-Ser-Phe-Val-Leu-Val-NH2 |
| A-4002 | Bactenecin | C63H118N24O13S2 | 1483.92 | 116229-36-8 | H-Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg-OH (Disulfide bond) |
| A-4003 | Beauvericin | C45H57N3O9 | 783.96 | 26048-05-5 | Cyclo(-D-α-hydroxyisovaleryl-N-Me-Phe)3 |
| A-4004 | Bombinin-Like Peptide, BLP-1 | C115H194N34O33 | 2581.02 | 138220-00-5 | H-Gly-Ile-Gly-Ala-Ser-Ile-Leu-Ser-Ala-Gly-Lys-Ser-Ala-Leu-Lys-Gly-Leu-Ala-Lys-Gly-Leu-Ala-Glu-His-Phe-Ala-Asn-NH2 |
| A-4005 | Brevinin-1 | C121H202N28O26S2 | 2529.24 | 145963-49-1 | H-Phe-Leu-Pro-Val-Leu-Ala-Gly-Ile-Ala-Ala-Lys-Val-Val-Pro-Ala-Leu-Phe-Cys-Lys-Ile-Thr-Lys-Lys-Cys-OH (Disulfide bond) |
| A-4006 | Dermaseptin | C152H257N43O44S2 | 3455.11 | 136033-70-0 | H-Ala-Leu-Trp-Lys-Thr-Met-Leu-Lys-Lys-Leu-Gly-Thr-Met-Ala-Leu-His-Ala-Gly-Lys-Ala-Ala-Leu-Gly-Ala-Ala-Ala-Asp-Thr-Ile-Ser-Gln-Gly-Thr-Gln-OH |
| A-4007 | Dermcidin-1L (human), DCD-1L (human) | C210H359N57O71 | 4818.5 | H-Ser-Ser-Leu-Leu-Glu-Lys-Gly-Leu-Asp-Gly-Ala-Lys-Lys-Ala-Val-Gly-Gly-Leu-Gly-Lys-Leu-Gly-Lys-Asp-Ala-Val-Glu-Asp-Leu-Glu-Ser-Val-Gly-Lys-Gly-Ala-Val-His-Asp-Val-Lys-Asp-Val-Leu-Asp-Ser-Val-Leu-OH | |
| A-4008 | Epinecidin-1 | C114H176N30O21S | 2334.91 | 1131706-77-8 | H-Gly-Phe-Ile-Phe-His-Ile-Ile-Lys-Gly-Leu-Phe-His-Ala-Gly-Lys-Met-Ile-His-Gly-Leu-Val-NH2 |
| A-4009 | Extracellular Death Factor, EDF | C27H36N10O10 | 660.64 | 960129-66-2 | H-Asn-Asn-Trp-Asn-Asn-OH |
| A-4010 | Hecate, Hecate-1 | C123H226N32O24 | 2537.35 | 133084-63-6 | H-Phe-Ala-Leu-Ala-Leu-Lys-Ala-Leu-Lys-Lys-Ala-Leu-Lys-Lys-Leu-Lys-Lys-Ala-Leu-Lys-Lys-Ala-Leu-OH |
| A-4011 | Indolicidin | C100H132N26O13 | 1906.32 | 140896-21-5 | H-Ile-Leu-Pro-Trp-Lys-Trp-Pro-Trp-Trp-Pro-Trp-Arg-Arg-NH2 |
| A-4012 | Parasin I | C82H154N34O24 | 2000.34 | 219552-69-9 | H-Lys-Gly-Arg-Gly-Lys-Gln-Gly-Gly-Lys-Val-Arg-Ala-Lys-Ala-Lys-Thr-Arg-Ser-Ser-OH |
| A-4013 | Ranalexin | C97H167N23O22S3 | 2103.73 | 155761-99-2 | H-Phe-Leu-Gly-Gly-Leu-Ile-Lys-Ile-Val-Pro-Ala-Met-Ile-Cys-Ala-Val-Thr-Lys-Lys-Cys-OH (Disulfide bond) |
| A-4014 | Sapecin | C164H266N58O52S6 | 4074.67 | 119938-54-4 | H-Ala-Thr-Cys-Asp-Leu-Leu-Ser-Gly-Thr-Gly-Ile-Asn-His-Ser-Ala-Cys-Ala-Ala-His-Cys-Leu-Leu-Arg-Gly-Asn-Arg-Gly-Gly-Tyr-Cys-Asn-Gly-Lys-Ala-Val-Cys-Val-Cys-Arg-Asn-OH (Disulfide bonds between Cys³ and Cys³⁰/Cys¹⁶ and Cys³⁶/Cys²⁰ and Cys³⁸) |
| A-4015 | Seminalplasmin Fragment (SPF) Analog, SPFK | C76H123N17O16 | 1530.92 | 147958-06-3 | H-Pro-Lys-Leu-Leu-Lys-Thr-Phe-Leu-Ser-Lys-Trp-Ile-Gly-OH |
| A-4016 | Tritrpticin | C96H132N28O14 | 1902.28 | 179264-81-4 | H-Val-Arg-Arg-Phe-Pro-Trp-Trp-Trp-Pro-Phe-Leu-Arg-Arg-OH |
| A-4017 | RIP | C45H55N9O12 | 913.99 | 228544-21-6 | H-Tyr-Ser-Pro-Trp-Thr-Asn-Phe-OH |
| A-4101 | H-Gly-Pro-Gly-NH2 | C9H16N4O3 | 264.71 | 141497-12-3 | H-Gly-Pro-Gly-NH2 · HCl |
| A-4102 | Fusion Inhibitory Peptide, FIP, Virus Replication Inhibitory Peptide | C28H29N3O6 | 503.56 | 75539-79-6 | Z-D-Phe-Phe-Gly-OH |
| A-4201 | H(-Arg-εAhx)6-Arg-OH | C78H152N34O14 | 1790.29 | 457633-17-9 | H-Arg-ε-aminocaproyl-Arg-ε-aminocaproyl-Arg-ε-aminocaproyl-Arg-ε-aminocaproyl-Arg-ε-aminocaproyl-Arg-ε-aminocaproyl-Arg-OH |
| A-4202 | Hexaarginine | C36H74N24O7 | 955.14 | 96337-25-6 | H-Arg-Arg-Arg-Arg-Arg-Arg-OH |
| A-4203 | Heptaarginine | C42H86N28O8 | 1111.33 | 165893-48-1 | H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH |
| A-4204 | Nonaarginine | C54H110N36O10 | 1423.7 | 143413-47-2 | H-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-OH |
| A-4301 | H-β-Asp-Gly-OH | C6H10N2O5 | 190.16 | 3790-52-1 | H-Asp(Gly-OH)-OH |
| A-4302 | H-β-Asp-His-OH | C10H14N4O5 | 270.25 | 20223-80-7 | H-Asp(His-OH)-OH |
| A-4303 | H-β-Asp-Leu-OH | C10H18N2O5 | 246.26 | 14650-26-1 | H-Asp(Leu-OH)-OH |
| B-0101 | BAM-12P | C62H97N21O16S | 1424.65 | 75513-71-2 | H-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-OH |
| B-0102 | BAM-12P (7-12) | C29H52N12O9 | 712.81 | 321940-50-5 | H-Arg-Val-Gly-Arg-Pro-Glu-OH |
| B-0103 | BAM-22P | C130H184N38O31S2 | 2839.26 | 76622-26-9 | H-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-OH |
| B-0104 | BAM-3200, Peptide E | C147H207N41O34S2 | 3156.65 | 78355-50-7 | H-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-Gly-Phe-Leu-OH |
| B-0201 | Band 3 Protein (547-553) (human) | C41H63N11O11 | 886.02 | 167095-71-8 | H-His-Pro-Leu-Gln-Lys-Thr-Tyr-OH |
| B-0202 | Band 3 Protein (824-829) (human) | C37H65N11O8 | 791.99 | 158475-15-1 | H-Tyr-Val-Lys-Arg-Val-Lys-OH |
| B-0301 | Bombesin | C71H110N24O18S | 1619.87 | 31362-50-2 | Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
| B-0301-2 | (Lys3)-Bombesin | C71H110N22O18S | 1591.86 | 66839-66-5 | Pyr-Gln-Lys-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
| B-0301-3 | (D-Phe12)-Bombesin | C74H112N22O18S | 1629.91 | 108437-87-2 | Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-D-Phe-Leu-Met-NH2 |
| B-0301-4 | (D-Phe12,Leu14)-Bombesin | C75H114N22O18 | 1611.87 | 108437-88-3 | Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-D-Phe-Leu-Leu-NH2 |
| B-0301-5 | (Tyr4)-Bombesin | C74H108N24O19S | 1669.89 | 67338-70-9 | Pyr-Gln-Arg-Tyr-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
| B-0301-6 | (Tyr4,D-Phe12)-Bombesin | C77H110N22O19S | 1679.92 | 108437-89-4 | Pyr-Gln-Arg-Tyr-Gly-Asn-Gln-Trp-Ala-Val-Gly-D-Phe-Leu-Met-NH2 |
| B-0302 | (D-Cys6,Asn7,D-Ala11,Cys14)-Bombesin (6-14) | C44H64N14O10S2 | 1013.21 | 349657-39-2 | H-D-Cys-Asn-Trp-Ala-Val-D-Ala-His-Leu-Cys-NH2 (Disulfide bond) |
| B-0302-2 | (D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14) | C49H69N13O9 | 984.17 | 124199-90-2 | H-D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-NHEt Trifluoroacetate salt |
| B-0302-3 | (D-Tyr6,βPhe11,Phe13,Nle14)-Bombesin (6-14) (free acid) | C63H79N13O12 | 1210.40 | H-D-Tyr-Gln-Trp-Ala-Val-βPhe-His-Phe-Nle-OH Trifluoroacetate salt | |
| B-0303 | Bombesin (8-14) | C38H57N11O7S | 812.01 | 55749-98-9 | H-Trp-Ala-Val-Gly-His-Leu-Met-NH2 |
| B-0304 | Cyclo(-D-Phe-His-Trp-Ala-Val-Gly-His-Leu-Leu) | C54H72N14O9 | 1061.26 | 143578-65-8 | Cyclo(-D-Phe-His-Trp-Ala-Val-Gly-His-Leu-Leu) |
| B-0401 | A-VI-5 | C22H40N6O10 | 548.59 | 39194-96-2 | H-Val-Glu-Ser-Ser-Lys-OH Acetate salt |
| B-0402 | Angiotensin I-Converting Enzyme Substrate | C24H27N3O5 | 437.50 | 69677-91-4 | Bz-Phe-Ala-Pro-OH |
| B-0403 | BPP 5a | C30H41N7O7 | 611.70 | 30505-63-6 | Pyr-Lys-Trp-Ala-Pro-OH |
| B-0404 | BPP 9a, Teprotide, SQ20881 | C53H76N14O12 | 1101.27 | 35115-60-7 | Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro-OH |
| B-0405 | Bradykinin Potentiator C | C51H77N11O13 | 1052.24 | 30953-20-9 | Pyr-Gly-Leu-Pro-Pro-Gly-Pro-Pro-Ile-Pro-Pro-OH |
| B-0406 | H-Pro-Thr-His-Ile-Lys-Trp-Gly-Asp-OH | C44H64N12O12 | 953.07 | 117620-76-5 | H-Pro-Thr-His-Ile-Lys-Trp-Gly-Asp-OH |
| B-0407 | H-Val-Trp-OH | C16H21N3O3 | 303.36 | 24587-37-9 | H-Val-Trp-OH |
| B-0501 | Bradykinin BK, Kallidin I, Kallidin-9, BRS-640 | C50H73N15O11 | 1060.22 | 6846-03-3 | H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH |
| B-0501-2 | (1-Adamantaneacetyl-D-Arg0,Hyp3,β-(2-thienyl)-Ala5·8,D-Phe7)-Bradykinin | C68H99N19O14S2 | 1470.79 | 130942-96-0 | 1-Adamantaneacetyl-D-Arg-Arg-Pro-Hyp-Gly-β-(2-thienyl)-Ala-Ser-D-Phe-β-(2-thienyl)-Ala-Arg-OH |
| B-0501-3 | (D-Arg0,Hyp2·3,D-Phe7)-Bradykinin | C60H87N19O14 | 1298.47 | 111929-26-1 | H-D-Arg-Arg-Hyp-Hyp-Gly-Phe-Ser-D-Phe-Phe-Arg-OH |
| B-0501-4 | (D-Arg0,Hyp3,D-Phe7)-Bradykinin | C60H87N19O13 | 1282.47 | 109333-26-8 | H-D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-D-Phe-Phe-Arg-OH Trifluoroacetate salt |
| B-0501-5 | (D-Arg0,Hyp3,D-Phe7,Leu8)-Bradykinin | C57H89N19O13 | 1248.45 | 135701-67-6 | H-D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-D-Phe-Leu-Arg-OH |
| B-0501-6 | (D-Arg0,Hyp3,β-(2-thienyl)-Ala5·8,D-Phe7)-Bradykinin, Hoe k86-4321, Ahtp-BK | C56H83N19O13S2 | 1294.53 | 103412-36-8 | H-D-Arg-Arg-Pro-Hyp-Gly-β-(2-thienyl)-Ala-Ser-D-Phe-β-(2-thienyl)-Ala-Arg-OH |
| B-0501-7 | (p-Chloro-Phe5·8)-Bradykinin | C50H71Cl2N15O11 | 1129.11 | 125229-63-2 | H-Arg-Pro-Pro-Gly-p-chloro-Phe-Ser-Pro-p-chloro-Phe-Arg-OH |
| B-0501-8 | (Des-Arg9)-Bradykinin | C44H61N11O10 | 904.04 | 15958-92-6 | H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-OH Acetate salt |
| B-0501-9 | (Des-Arg9,Leu8)-Bradykinin | C41H63N11O10 | 870.02 | 64695-06-3 | H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu-OH |
| B-0501-10 | (Hyp3)-Bradykinin | C50H73N15O12 | 1076.22 | 37642-65-2 | H-Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg-OH Acetate salt |
| B-0501-11 | Lys-Bradykinin Kallidin | C56H85N17O12 | 1188.40 | 342-10-9 | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Acetate salt |
| B-0502 | Lys-Bradykinin-Ser-Val-Gln-Val-Ser | C77H121N23O20 | 1688.95 | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-Ser-Val-Gln-Val-Ser-OH | |
| B-0502-2 | Lys-(Ala3)-Bradykinin | C54H83N17O12 | 1162.36 | 103545-18-2 | H-Lys-Arg-Pro-Ala-Gly-Phe-Ser-Pro-Phe-Arg-OH Acetate salt |
| B-0502-3 | Lys-(Des-Arg9)-Bradykinin (Des-Arg10)-Kallidin | C50H73N13O11 | 1032.21 | 71800-36-7 | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-OH Trifluoroacetate salt |
| B-0502-4 | Lys-(Des-Arg9,Leu8)-Bradykinin (Des-Arg10,Leu9)-Kallidin | C47H75N13O11 | 998.19 | 71800-37-8 | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu-OH Trifluoroacetate salt |
| B-0502-5 | Lys-(Hyp3)-Bradykinin | C56H85N17O13 | 1204.40 | 113662-39-8 | H-Lys-Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg-OH |
| B-0502-6 | Lys-(Tyr8)-Bradykinin (Tyr9)-Kallidin | C56H85N17O13 | 1204.40 | H-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg-OH | |
| B-0502-7 | Lys-Lys-(Hyp3,β-(2-thienyl)-Ala5·8,D-Phe7)-Bradykinin | C62H95N19O14S2 | 1394.69 | 103412-40-4 | H-Lys-Lys-Arg-Pro-Hyp-Gly-β-(2-thienyl)-Ala-Ser-D-Phe-β-(2-thienyl)-Ala-Arg-OH |
| B-0503 | Mca-(Ala7,Lys(Dnp)9)-Bradykinin | C66H81N15O19 | 1388.46 | 323577-36-2 | Mca-Arg-Pro-Pro-Gly-Phe-Ser-Ala-Phe-Lys(Dnp)-OH Trifluoroacetate salt |
| B-0501-12 | (N-Me-D-Phe7)-Bradykinin | C55H77N15O11 | 1124.31 | 158873-14-4 | H-Arg-Pro-Pro-Gly-Phe-Ser-N-Me-D-Phe-Phe-Arg-OH |